Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I trial of KSP-0914 in Japanese and Caucasian healthy adult volunteers
jRCT2071250084Phase 1Recruiting
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of KSP-0914 in Graves' disease, sponsored by Kissei Pharmaceutical Co., Ltd. Primary endpoints: Incidence of adverse events and adverse drug reactions and Plasma concentrations and pharmacokinetic profile of KSP-0914 and metabolites. Started Sep 2025; status: recruiting.
02
Drugs
KSP-0914
03
Conditions
Graves' disease
Beyond the preview
Go deeper on jRCT2071250084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071250084.